| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21OH012955 | Translation of the Aging and Immunity Multiome (TAIM): a Pilot Lifestyle Investigation in WTC Exposed FDNY Responders | 01 | 1 | CDC | 11/17/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012778 | Integrated analysis of cancer risk and mortality in WTC survivors | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012637 | Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population | 01 | 3 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012486 | Cognitive decline among WTC survivors with chronic mental and physical disorders | 01 | 4 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012069 | Aerodigestive Disease in the World Trade Center Exposed FDNY Cohort: Validation of Biomarkers and Defining Risk to Tailor Therapy | 02 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011855 | World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach | 01 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01NS136023 | Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | 000 | 3 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01OH012795 | Microbiome Targeted Treatment of WTC- Lung Injury | 01 | 2 | CDC | 11/17/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01OH012794 | World Trade Center Particulate Matter-Associated End Organ Dysfunction: Targeting Early Vascular Dysfunction and Injury | 01 | 2 | CDC | 11/17/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | NU58DP006911 | NYU BOLD Public Health Center of Excellence on Early Detection of Dementia | 02 | 5 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011300 | Metabolomics of World Trade Center-Lung Injury: Biomarker Validation, Longitudinal Assessment and Dietary Intervention | 01 | 8 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011300 | Metabolomics of World Trade Center-Lung Injury: Biomarker Validation, Longitudinal Assessment and Dietary Intervention | 01 | 8 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012778 | Integrated analysis of cancer risk and mortality in WTC survivors | 01 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012637 | Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population | 01 | 3 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012486 | Cognitive decline among WTC survivors with chronic mental and physical disorders | 01 | 4 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012069 | Aerodigestive Disease in the World Trade Center Exposed FDNY Cohort: Validation of Biomarkers and Defining Risk to Tailor Therapy | 02 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | NU58DP006911 | NYU BOLD Public Health Center of Excellence on Early Detection of Dementia | 02 | 5 | CDC | 11/10/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01OH012795 | Microbiome Targeted Treatment of WTC- Lung Injury | 01 | 2 | CDC | 11/17/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01OH012794 | World Trade Center Particulate Matter-Associated End Organ Dysfunction: Targeting Early Vascular Dysfunction and Injury | 01 | 2 | CDC | 11/17/2025 | $0 |
| | 2026 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011855 | World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach | 01 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011300 | Metabolomics of World Trade Center-Lung Injury: Biomarker Validation, Longitudinal Assessment and Dietary Intervention | 01 | 8 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012637 | Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population | 01 | 3 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012486 | Cognitive decline among WTC survivors with chronic mental and physical disorders | 01 | 4 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012069 | Aerodigestive Disease in the World Trade Center Exposed FDNY Cohort: Validation of Biomarkers and Defining Risk to Tailor Therapy | 02 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012069 | Aerodigestive Disease in the World Trade Center Exposed FDNY Cohort: Validation of Biomarkers and Defining Risk to Tailor Therapy | 02 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011855 | World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach | 01 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2022 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011300 | Metabolomics of World Trade Center-Lung Injury: Biomarker Validation, Longitudinal Assessment and Dietary Intervention | 01 | 8 | CDC | 11/13/2025 | $0 |
| | 2026 | 2022 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012486 | Cognitive decline among WTC survivors with chronic mental and physical disorders | 01 | 4 | CDC | 11/13/2025 | $0 |
| | 2026 | 2022 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012069 | Aerodigestive Disease in the World Trade Center Exposed FDNY Cohort: Validation of Biomarkers and Defining Risk to Tailor Therapy | 02 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2022 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH012069 | Aerodigestive Disease in the World Trade Center Exposed FDNY Cohort: Validation of Biomarkers and Defining Risk to Tailor Therapy | 02 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2022 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011855 | World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach | 01 | 5 | CDC | 11/13/2025 | $0 |
| | 2026 | 2021 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01OH011855 | World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach | 01 | 5 | CDC | 11/13/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $432,418,728 ) (Continued on the next page) |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U24HL155811 | 2/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial) –DCC | 001 | 4 | NIH | 8/4/2025 | $570,142 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00CA279648 | Understanding the developmental perspective of mammary lineage commitment to model breast cancer | 000 | 2 | NIH | 8/15/2025 | $248,999 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01AG092910 | Deciphering the selective vulnerability of basal forebrain cholinergic neurons to tauopathy | 000 | 1 | NIH | 7/8/2025 | $130,302 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018528 | Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations | 001 | 3 | NIH | 3/31/2025 | $694,908 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | RF1MH130238 | When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective | 000 | 4 | NIH | 8/19/2025 | $1,375,435 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01DK140613 | Community-Engaged Approach to Supporting South Asians w/ Type 2 Diabetes at Risk for Depression | 000 | 1 | NIH | 7/15/2025 | $158,943 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS127129 | The Neural Circuit Basis of Olfactory Navigation in Adult Drosophila | 001 | 2 | NIH | 6/24/2025 | $141,454 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS127129 | The Neural Circuit Basis of Olfactory Navigation in Adult Drosophila | 000 | 2 | NIH | 3/12/2025 | $550,595 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30HL167568 | The role of Immune-responsive gene 1 and itaconate in atherosclerotic disease | 001 | 3 | NIH | 6/9/2025 | $564 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P30CA016087 | Cancer Center Support Grant | 005 | 44 | NIH | 5/22/2025 | $398,437 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P30CA016087 | Cancer Center Support Grant | 004 | 44 | NIH | 4/7/2025 | $3,585,950 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99DC021729 | How myelin regulates vestibular circuit function and balance behaviors | 000 | 2 | NIH | 3/4/2025 | $129,168 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA271622 | Deep-learning Integration of Histopathology and Proteogenomics at a Pan-cancer Level - Resubmission | 001 | 3 | NIH | 5/22/2025 | $188 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30CA271622 | Deep-learning Integration of Histopathology and Proteogenomics at a Pan-cancer Level - Resubmission | 000 | 3 | NIH | 2/18/2025 | $20,109 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL169798 | Optimizing the allocation of hearts from deceased donors | 000 | 2 | NIH | 2/14/2025 | $762,743 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL169798 | Optimizing the allocation of hearts from deceased donors | 001 | 2 | NIH | 8/28/2025 | $84,749 |
|
